Citations

Showing 10 of 108119 citations.

Physiological Impact of Hypothermia: The Good, the Bad, and the Ugly
Tveita, Torkjel , Sieck, Gary C. , Sieck, Gary , Tveita, Torkjel

Mayo Clinic

Physiology | October 11, 2021 | Volume: 37 | Issue: 2 | Pages: 69-87

10.1152/physiol.00025.2021 | PMID 34632808 Get It

Hypothermia is defined as a core body temperature of <35°C, and as body temperature is reduced the impact on physiological processes can be beneficial or detrimental. The beneficial effect of hypothermia enables circulation of cooled experimental animals to be interrupted for 1–2 h without creating harmful effects, while tolerance of circulation arrest in normothermia is between 4 and 5 min. This striking difference has attracted so many investigators, experimental as well as clinical, to this field, and this discovery was fundamental for introducing therapeutic hypothermia in modern clinical medicine in the 1950s. Together with the introduction of cardiopulmonary bypass, therapeutic hypothermia has been the cornerstone in the development of modern cardiac surgery. Therapeutic hypothermia also has an undisputed role as a protective agent in organ transplantation and as a therapeutic adjuvant for cerebral protection in neonatal encephalopathy. However, the introduction of therapeutic hypothermia for organ protection during neurosurgical procedures or as a scavenger after brain and spinal trauma has been less successful. In general, the best neuroprotection seems to be obtained by avoiding hyperthermia in injured patients. Accidental hypothermia occurs when endogenous temperature control mechanisms are incapable of maintaining core body temperature within physiologic limits and core temperature becomes dependent on ambient temperature. During hypothermia spontaneous circulation is considerably reduced and with deep and/or prolonged cooling, circulatory failure may occur, which may limit safe survival of the cooled patient. Challenges that limit safe rewarming of accidental hypothermia patients include cardiac arrhythmias, uncontrolled bleeding, and “rewarming shock.”
Exome Sequencing of Pancreatic Acinar Carcinoma Identified Distinctive Mutation Patterns
Liu, Yuanhang , Wallace, Michael B. , Mody, Kabir , Zhang, Lizhi , Ji, Baoan , Bi, Yan , Wallace, Michael B , Raimondo, Massimo , Stauffer, John

Mayo Clinic

Pancreas | October 11, 2021 | Volume: 50 | Issue: 7 | Pages: 1007-1013

10.1097/mpa.0000000000001870 | PMID 34629449 Get It

Objectives Pancreatic acinar cell carcinoma (ACC) is a rare pancreatic cancer. The advancement of treatment is hampered because of the limited knowledge of its molecular mechanism. Methods Whole-exome sequencing was performed on DNA extracted from 11 pure ACC surgical samples. Potential germline variants were removed on the basis of polymorphic databases, alternative allele frequency, coverage depth, and Catalogue of Somatic Mutations in Cancer (COSMIC) annotations after variant calling procedure. Mutation profiles and signatures were assessed through the Mutational Patterns package. Results A median of 34 somatic mutations were detected (range, 19–60). Three novel recurrent small deletions were identified. Common pancreatic ductal adenocarcinoma mutations or neuroendocrine tumor mutants were not found. FAT atypical cadherin 4, mucin 5B, titin, and zinc finger homeobox 3 were consistently mutated across 4 independent ACC studies. A high contribution of COSMIC mutational signature 1 was seen in ACC, indicating deamination of 5-methylcytosine. The majority of the patients had COSMIC signatures 6, 15, or 20, relating to defective DNA mismatch repair. Six patients showed COSMIC mutational signature 10 because of the altered activity of DNA polymerase epsilon. Conclusions Distinct mutational signatures pathways were found in ACC and targeting them may improve clinical outcome.
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers
Weinberg, David S. , Foster, Nathan R. , Della’Zanna, Gary , Pallotto, Angela, Katz, Leo C., Henry, Christopher , Moleski, Stephanie , McMurray, Ryan P. , Limburg, Paul J. , Waldman, Scott A , Kraft, Walter K. , Kastenberg, David , Waldman, Scott A.

Mayo Clinic

Cancer Biology & Therapy | October 11, 2021 | Volume: 22 | Issue: 10-12 | Pages: 544-553

10.1080/15384047.2021.1967036 | PMID 34632925 Get It

Identification of Novel Rodent-Borne Orthohantaviruses in an Endemic Area of Chronic Kidney Disease of Unknown Etiology (CKDu) in Sri Lanka
Muthusinghe, Devinda S. , Shimizu, Kenta , Lokupathirage, Sithumini M. W., Wei, Zhouoxing , Sarathkumara, Yomani D. , Fonseka, G. R. A. , Senarathne, P. , Koizumi, Nobuo , Koizumi, Akio , Wickramasinghe, Chaminda, Tsuda, Yoshimi , Arikawa, Jiro , Yoshimatsu, Kumiko , Fonseka, G R Amanda , Matsuno, Keita , Gamage, Chandika D , Yoshimatsu, Kumiko , Kawakami, Tomonori , Ebihara, Hideki

Mayo Clinic

Viruses | October 11, 2021 | Volume: 13 | Issue: 10 | Pages: 1984

10.3390/v13101984 | PMID 34696414 Get It

We reported the genetic evidence of circulating hantaviruses from small mammals captured in a chronic kidney disease of unknown etiology (CKDu) hotspot area of Sri Lanka. The high seroprevalence of anti-hantavirus antibodies against Thailand orthohantavirus (THAIV) has been reported among CKDu patients and rodents in Sri Lankan CKDu hotspots. We captured 116 small mammals from CKDu endemic regions in the Polonnaruwa District of Sri Lanka. Seven animals (five out of 11 Mus booduga and two out of 99 Rattus rattus) were PCR-positive for the hantavirus. A rat-borne sequence was grouped with a THAIV-like Anjozorobe virus. In contrast, Mus-borne sequences belonged to the THAIV lineage, suggesting a novel orthohantavirus species according to the phylogenetic analyses and whole-genome comparisons. Our genetic evidence indicates the presence of two THAIV-related viruses circulating in this CKDu endemic area, suggesting a basis for further investigations to identify the infectious virus in patients with CKDu and the CKDu induction mechanism of these viruses.
Clinical studies sponsored by digital health companies participating in the FDA’s Precertification Pilot Program: A cross-sectional analysis
Bartlett, Victoria , Dhruva, Sanket S. , Shah, Nilay D. , Ross, Joseph S. , Bartlett, Victoria L , Ross, Joseph S

Mayo Clinic

Clinical Trials | October 11, 2021 | Volume: 19 | Issue: 1 | Pages: 119-122

10.1177/17407745211048493 | PMID 34632824 Get It

Samuel Alan Yousem, MD (October 17, 1956 to August 17, 2021)
Colby, Thomas V., Myers, Jeffrey L., Colby, Thomas V., Myers, Jeffrey L.

Mayo Clinic

American Journal of Surgical Pathology | October 11, 2021 | Volume: 45 | Issue: 12 | Pages: 1732-1733

10.1097/pas.0000000000001823 Get It

Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence Variants
Prakash, Amol , Taylor, Lorne , Varkey, Manu, Hoxie, Nate , Mohammed, Yassene , Goo, Young Ah , Peterman, Scott, Yuan, Yuting , Glaros, Trevor , Steele, Joel R. , Faridi, Pouya , Parihari, Shashwati , Srivastava, Sanjeeva , Otto, Joseph J. , Semmes, O. John , Moran, Michael F. , Madugundu, Anil K. , Mun, Dong Gi, Pandey, Akhilesh , Mahoney, Keira E. , Shabanowitz, Jeffrey , Saxena, Satya, Steele, Joel R , Faridi, Pouya , Parihari, Shashwati , Srivastava, Sanjeeva , Semmes, O John , Moran, Michael F , Pandey, Akhilesh , Pandey, Akhilesh , Shabanowitz, Jeffrey , Moghekar, Abhay , Nyalwidhe, Julius O. , Orsburn, Benjamin C.

Mayo Clinic

Cancers | October 10, 2021 | Volume: 13 | Issue: 20 | Pages: 5034

10.3390/cancers13205034 | PMID 34680183 Get It

The Clinical Proteomic Tumor Analysis Consortium (CPTAC) has provided some of the most in-depth analyses of the phenotypes of human tumors ever constructed. Today, the majority of proteomic data analysis is still performed using software housed on desktop computers which limits the number of sequence variants and post-translational modifications that can be considered. The original CPTAC studies limited the search for PTMs to only samples that were chemically enriched for those modified peptides. Similarly, the only sequence variants considered were those with strong evidence at the exon or transcript level. In this multi-institutional collaborative reanalysis, we utilized unbiased protein databases containing millions of human sequence variants in conjunction with hundreds of common post-translational modifications. Using these tools, we identified tens of thousands of high-confidence PTMs and sequence variants. We identified 4132 phosphorylated peptides in nonenriched samples, 93% of which were confirmed in the samples which were chemically enriched for phosphopeptides. In addition, our results also cover 90% of the high-confidence variants reported by the original proteogenomics study, without the need for sample specific next-generation sequencing. Finally, we report fivefold more somatic and germline variants that have an independent evidence at the peptide level, including mutations in ERRB2 and BCAS1. In this reanalysis of CPTAC proteomic data with cloud computing, we present an openly available and searchable web resource of the highest-coverage proteomic profiling of human tumors described to date.
Effect of Topical Phenylephrine 2.5% on Episcleral Venous Pressure in Normal Human Eyes
Kazemi, Arash , McLaren, Jay W. , Sit, Arthur J. , Sit, Arthur J

Mayo Clinic

Investigative Opthalmology & Visual Science | October 10, 2021 | Volume: 62 | Issue: 13 | Pages: 4

10.1167/iovs.62.13.4 | PMID 34617960 Get It

Severity of dysphagia is associated with hospitalizations and mortality in patients with Parkinson’s disease
Dilmaghani, Saam , Atieh, Jessica , Khanna, Lehar, Hosfield, Emily A., Camilleri, Michael , Katzka, David A.

Mayo Clinic

Neurogastroenterology & Motility | October 10, 2021 | Volume: 34 | Issue: 6 | Pages: No page available

10.1111/nmo.14280 | PMID 34628711 Get It

AbstractBackgroundAspiration pneumonia is the commonest cause of hospitalizations and death in patients with Parkinson's disease (PD). Among these patients, the relationships between severity of dysphagia, hospitalizations for related complications, and death are not robustly defined. Our aim was to characterize the relationship between PD‐related oropharyngeal dysfunction and clinically relevant outcomes.MethodsRetrospective cohort study of 312 patients with PD at a tertiary center who underwent videofluoroscopic swallow studies conducted by expert therapists between 2010 and 2015. Level of swallowing function was represented using the 7‐point Functional Oral Intake Scale (FOIS) (7 = normal function). Significance and relative risk calculations utilized Poisson regression. Time to composite outcome of first hospitalization or death was summarized using Kaplan‐Meier curve with log‐rank test.Key ResultsOne hundred thirty eight patients had a recorded FOIS score. The prevalence of oropharyngeal dysfunction was 76.1%. The median duration of follow‐up was 26.8 months. In multivariate analyses, patients with FOIS 5 (RR = 2.01 [95% CI: 1.22, 3.32]), FOIS 3 (RR = 2.78 [95% CI: 1.75, 4.40]), and FOIS 1 (RR = 2.50 [95% CI: 1.49, 4.20]) were significantly associated with increased risk of hospitalization or death compared to FOIS 7 after co‐variate adjustments. GERD was also associated with a significant increased risk of hospitalization or death (RR = 1.28 [95% CI: 1.01, 1.64]). Time to first hospitalization or death was shorter in patients with lower FOIS scores (p < 0.00005).Conclusions and InferencesSeverity of oropharyngeal dysphagia, as measured by the FOIS, is associated with poorer survival and shorter time to hospitalization for dysphagia‐related complications, pneumonia, or death in PD.
Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population‐based study
Irani, Mudar Zand, Jones, Michael , Halland, Magnus , Herrick, Linda M., Choung, Rok Seon , Saito, Yuri A. , Walker, Marjorie M. , Murray, Joseph A. , Talley, Nicholas J. , Talley, Nicholas J. , Jones, Michael P , Herrick, Linda, Saito, Y A , Murray, J A , Choung, Rok Seon

Mayo Clinic

Alimentary Pharmacology & Therapeutics | October 10, 2021 | Volume: 54 | Issue: 11-12 | Pages: 1416-1431

10.1111/apt.16630 | PMID 34626489 Get It

SummaryBackgroundRumination syndrome is a functional gastroduodenal disorder characterised by effortless regurgitation of recently ingested food. Emerging evidence reports duodenal eosinophilic inflammation in a subset, suggesting a shared pathophysiology with functional dyspepsia (FD).AimTo assess the clinical features of rumination syndrome and FD in a community‐based study.MethodsWe mailed a survey assessing gastrointestinal symptoms, diet and psychological symptoms to 9835 residents of Olmsted County, MN, USA in 2017‐2018; diagnostic codes were obtained from linked clinical records. The two disorders were assessed as mutually exclusive in ‘pure’ forms with a separate overlap group, all compared to a control group not meeting criteria for either. Prevalence of associations, and univariate and independent associations with predictors were assessed by logistic regression.ResultsPrevalence of rumination syndrome and FD were 5.8% and 7.1%, respectively; the overlap was 3.83‐times more likely than expected by chance. Independent predictors for rumination (odds ratio (OR), 95% confidence interval (CI)) were female gender (1.79, 1.21‐2.63), smoking (1.89, 1.28‐2.78), gluten‐free diet (1.58, 1.14‐2.19), allergic rhinitis (1.45, 1.01‐2.08) and depression (1.10, 1.05‐1.16). FD was independently associated with female gender, depression, non‐coeliac wheat sensitivity, migraine, irritable bowel syndrome and somatic symptoms. A similar reported efficacy (≥54%) of low fat or dairy‐free diets was found with both disorders (P = 0.53 andP = 1.00, respectively). The strongest independent associations with overlapping FD and rumination syndrome were a history of rheumatoid arthritis (3.93, 1.28‐12.06) and asthma (3.02, 1.44‐6.34).ConclusionRumination syndrome overlaps with FD with a shared risk factor profile, suggesting a common pathophysiology.